Latest articles
Help ensure secondary breast cancer is placed high on the health agenda.
Emma Pennery, Clinical Director at Breast Cancer Care says: “Kadcyla being rejected from routine NHS access will come as another devastating blow to women with HER-2 positive advanced breast cancer, denying them the chance of a longer and much better quality of life”.
-01.png){kind=spacer}